Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL160605

CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.52
KCNH2 Q12809 7/20 0.46
SLC22A2 O15244 1/20 0.46
EPHX1 P07099 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DNM1 Q05193 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL30789018 1.00 SLC22A1 (0.52) SLC22A1KCNH2SLC22A2EPHX1ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL28585900 0.96 SLC22A1 (0.52) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL302110 0.96 SLC22A1 (0.52) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL15466216 0.96 SLC22A1 (0.52) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Tetrapentylammonium SCHEMBL2862362 0.96 SLC22A1 (0.52) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL28812353 0.94 SLC22A1 (0.54) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Trifluoromethanesulfonic Acid SCHEMBL2857295 0.94 SLC22A1 (0.54) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Tetrahexylammonium SCHEMBL2862380 0.94 SLC22A1 (0.54) SLC22A1KCNH2SLC22A2ALDH1A1TP53
Tetrabuthylammonium SCHEMBL31555937 0.92 SLC22A1 (0.44) SLC22A1KCNH2SLC22A2EPHX1ALDH1A1
Tetrabuthylammonium SCHEMBL1363406 0.92 SLC22A1 (0.44) SLC22A1KCNH2SLC22A2EPHX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 963 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260045538-A1 Catalyst for Lithium-Sulfur Batteries UNIV NORTHEASTERN (US) 2026-02-12 US claimed
CN-119977847-A Alkyl carboxylic acid-based18Synthesis method of F-labeled alkylsulfonyl fluoride molecule 华中科技大学同济医学院附属同济医院 2025-05-13 CN claimed
CN-119841745-A High-valence iodine (III) carboxylate18Synthesis method of F-labeled alkylsulfonyl fluoride molecule 华中科技大学同济医学院附属同济医院 2025-04-18 CN claimed
CN-119657205-A CTA hydrofining catalyst and preparation method and application thereof 中国石油化工股份有限公司 2025-03-21 CN claimed
CN-119546143-A Design and manufacture of submicron texture silicon substrate heterojunction 青海黄河上游水电开发有限责任公司西宁太阳能电力分公司 2025-02-28 CN claimed
CN-118996447-A Phosphine-oxide substituted quinoxaline quinazolinone compound, preparation method and application thereof 南阳师范学院 2024-11-22 CN claimed
CN-118725235-A Metalloporphyrin polyurethane, synthesis method thereof and application thereof in electrocatalytic oxidation of organic matters 广东石油化工学院 2024-10-01 CN claimed
EP-3320562-B1 FORMULATIONS TO SELECTIVELY ETCH SILICON GERMANIUM RELATIVE TO GERMANIUM ENTEGRIS INC (US) 2024-08-28 EP claimed
US-20240264106-A1 SYSTEMS, APPARATUSES, AND METHODS FOR DETECTING A VAPOR HONEYWELL INTERNATIONAL INC. 2024-08-08 US claimed
EP-4411359-A1 SYSTEMS, APPARATUSES, AND METHODS FOR DETECTING A VAPOR Honeywell International Inc. (US) 2024-08-07 EP claimed
US-5304449-A Toner and developer compositions with pyridinium compounds and tetrasubstituted ammonium salts as charge enhancing additives XEROX CORPORATION (US) 1994-04-19 US claimed
US-5239405-A Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same DONNELLY CORPORATION (US) 1993-08-24 US claimed
US-5194490-A Polyelectrolytes for lithium cells NIPPON OIL CO., LTD. (JP) 1993-03-16 US claimed
US-5053293-A Doped polythiophene on semiconductor, solid electrolytes AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1991-10-01 US claimed
EP-0446793-A1 Preparation process of polymeric solid electrolyte Nippon Oil Co., Ltd. (JP) 1991-09-18 EP claimed
US-4978473-A Copolymers of acrylated ethylene glycols with acrylic nitriles or esters blended with alkali metal or quaternary ammonium salts NIPPON OIL CO., LTD. (JP) 1990-12-18 US claimed
US-4970012-A CINNAMATE ESTER OF POLYOXYETHYLENE GLYCOL NIPPON OIL COMPANY, LTD. (JP) 1990-11-13 US claimed
US-4849531-A Process for the preparation of 2,3-epoxyamides BAYER AKTIENGESELLSCHAFT (DE) 1989-07-18 US claimed
EP-0244717-A2 Process for the preparation of 2,3-epoxyamides BAYER AG (DE) 1987-11-11 EP claimed
US-4647348-A Method for production of film-coated silicon semiconductor electrode AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) 1987-03-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260045538-A1 Catalyst for Lithium-Sulfur Batteries KCNA4, CACNA2D4, KCNA1 SLC22A1 799/4885KCNH2 88/4885SLC22A2 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.